We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+2.16%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$119M
AUM Growth
+$3.11M
Cap. Flow
+$619K
Cap. Flow %
0.52%
Top 10 Hldgs %
22.99%
Holding
184
New
25
Increased
49
Reduced
67
Closed
21

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.48M
2
ADI icon
Analog Devices
ADI
+$1.13M
3
PRXL
Parexel International Corp
PRXL
+$1.1M
4
MSFT icon
Microsoft
MSFT
+$969K
5
JWN
Nordstrom
JWN
+$833K

Sector Composition

Rank Sector Weight
1 Industrials 18.45%
2 Healthcare 16.9%
3 Consumer Staples 13.84%
4 Financials 13.02%
5 Consumer Discretionary 11.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHD icon
1
Church & Dwight Co
CHD
$23.4B
$5.49M 4.6%
114,600
-800
-0.7% -$39.5K
JNJ icon
2
Johnson & Johnson
JNJ
$618B
$3.58M 3%
30,343
+5,063
+20% +$614K
KMB icon
3
Kimberly-Clark
KMB
$36.3B
$3.07M 2.57%
24,338
-400
-2% -$51.7K
GE icon
4
GE Aerospace
GE
$374B
$2.67M 2.24%
18,839
+1,697
+10% +$253K
XOM icon
5
ExxonMobil
XOM
$644B
$2.66M 2.23%
30,468
-2,058
-6% -$183K
WASH icon
6
Washington Trust Bancorp
WASH
$743M
$2.54M 2.13%
63,093
-1,000
-2% -$40.1K
WFC icon
7
Wells Fargo
WFC
$261B
$2.06M 1.72%
46,447
+3,050
+7% +$146K
PFE icon
8
Pfizer
PFE
$143B
$2M 1.68%
62,257
+15,512
+33% +$519K
URI icon
9
United Rentals
URI
$67.2B
$1.7M 1.42%
21,600
+9,525
+79% +$730K
VLO icon
10
Valero Energy
VLO
$90.1B
$1.66M 1.39%
31,225
+1,225
+4% +$65.3K
DIS icon
11
Walt Disney
DIS
$167B
$1.63M 1.37%
17,575
+1,400
+9% +$134K
INTC icon
12
Intel
INTC
$455B
$1.62M 1.36%
42,883
-4,950
-10% -$175K
CSX icon
13
CSX Corp
CSX
$93.4B
$1.55M 1.3%
152,589
+28,650
+23% +$271K
CELG
14
DELISTED
Celgene Corp
CELG
$1.54M 1.29%
14,755
-3,000
-17% -$325K
TFC icon
15
Truist Financial
TFC
$63.3B
$1.53M 1.29%
40,690
-3,450
-8% -$129K
AAPL icon
16
Apple
AAPL
$4.54T
$1.45M 1.22%
51,340
-3,020
-6% -$79.9K
BA icon
17
Boeing
BA
$171B
$1.45M 1.21%
10,990
+1,190
+12% +$157K
CSCO icon
18
Cisco
CSCO
$457B
$1.43M 1.2%
45,150
-12,250
-21% -$377K
AB icon
19
AllianceBernstein
AB
$3.43B
$1.42M 1.19%
62,088
+5,850
+10% +$132K
CVS icon
20
CVS Health
CVS
$133B
$1.32M 1.11%
14,885
+4,200
+39% +$396K
DRI icon
21
Darden Restaurants
DRI
$23.3B
$1.31M 1.1%
21,350
+12,350
+137% +$766K
NKE icon
22
Nike
NKE
$61.9B
$1.26M 1.06%
24,027
-1,150
-5% -$64.9K
PG icon
23
Procter & Gamble
PG
$336B
$1.24M 1.04%
13,826
+1,546
+13% +$134K
K
24
DELISTED
Kellanova
K
$1.23M 1.03%
16,968
-426
-2% -$32.6K
MMM icon
25
3M
MMM
$90.9B
$1.22M 1.02%
8,262

Similar funds

New England Research & Management's Q3 2016 Portfolio in Review

As of Q3 2016, New England Research & Management held 184 positions worth $119M, up 2.7% from $116M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

New England Research & Management's Q3 2016 filing shows 25 new, 49 increased, 67 reduced and 21 closed positions. Its largest new stake was Installed Building Products: 19,900 shares worth $714K. The largest sale was Merck, an estimated $1.48M.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Staples.

  • New England Research & Management's largest Q3 2016 buy was Installed Building Products: 19,900 shares worth $714K.
  • New England Research & Management added most to Bristol-Myers Squibb in Q3 2016, an estimated $881K increase.
  • New England Research & Management's biggest Q3 2016 reduction was Merck, cutting an estimated $1.48M.
  • New England Research & Management fully exited Analog Devices in Q3 2016, selling an estimated $1.13M.
  • New England Research & Management's ten largest holdings make up 23% of its $119M portfolio in Q3 2016.
  • New England Research & Management opened 25 new positions and closed 21 in Q3 2016.
  • New England Research & Management's portfolio value rose 2.7% quarter-over-quarter to $119M.

Based on New England Research & Management's 13F filing for Q3 2016, filed 5 Oct 2016.